#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dedifferentiated liposarcoma Chronic lymphocytic leukaemia recurrent Subarachnoid haemorrhage Chondrosarcoma Non-small cell lung cancer metastatic Neuropathy peripheral Peripheral primitive neuroectodermal tumour of soft tissue Colorectal cancer metastatic Malignant central nervous system neoplasm Head and neck cancer Immunoglobulin G4 related disease Systemic candida Langerhans cell sarcoma Chronic hepatitis B Hypophosphatasia More trials…

    Learn about Rare Diseases

    Mastocytosis – Trials in Disease Immunodeficiency congenital Gastrointestinal stromal tumour – Basic Information Lymphangiosarcoma Mucopolysaccharidosis I – Life with Disease X-linked lymphoproliferative syndrome – Trials in Disease Metachromatic leukodystrophy – Diagnostics Langerhans’ cell histiocytosis – Treatment Systemic mastocytosis – Basic Information Richter’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tiaprofenic Acid Heparin Fosinopril Sodium PICLIDENOSON Prasugrel ANTIMETABOLITES Kk8123 Radiprodil Saruparib Ruxotemitide Tx200-Tr101 Blu-263 Phosphate Ripasudil Human Immunoglobulin G Dexketoprofen Siremadlin Tocilizumab Human Cancellous Bone Boserolimab SAR444336 More therapies…

    Learn about Your Condition

    Uterine leiomyoma Rett syndrome Urinary incontinence Diabetic gastroparesis Rhinitis allergic Coronary artery dissection Juvenile idiopathic arthritis Phaeochromocytoma Behcet's syndrome Atrophic vulvovaginitis Obliterative bronchiolitis Thromboangiitis obliterans Tinnitus Antisynthetase syndrome Gaucher's disease type I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gaucher’s disease type III

  • Efficacy and safety of oral venglustat versus intravenous imiglucerase in children aged 2‑11 years with Gaucher disease type 3

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Gaucher’s disease type III
    Investigated Drugs:
    • Imiglucerase
    • Venglustat
    Finland France Germany Hungary Italy Spain

  • Study on the Effectiveness and Safety of Venglustat for Adults and Children with Gaucher Disease Type 3

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Gaucher’s disease type III
    Investigated Drugs:
    • Imiglucerase
    • Venglustat
    France Germany Italy

  • Study of Eliglustat alone or with Imiglucerase in children and adolescents aged 2-17 years with Gaucher disease type 1 and type 3

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Gaucher’s disease type I
    • Gaucher’s disease type III
    Investigated Drugs:
    • Eliglustat Tartrate
    • Imiglucerase
    France Italy Spain

  • Study of Venglustat and Imiglucerase for Adult Patients with Gaucher Disease Type 3

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gaucher’s disease type I
    • Gaucher’s disease type III
    Investigated Drugs:
    • Imiglucerase
    • Venglustat
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!